Palisade Capital Management’s Merck MRK Stock Holding History

Palisade Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$242K	Hold	2,014	–	–	0.01%	296
2025 Q4	$212K	Buy	+2,014	New	+$189K	0.01%	375
2025 Q3	–	Sell	-2,591	Closed	-$205K	–	374
2025 Q2	$205K	Buy	+2,591	New	+$206K	0.01%	364
2024 Q4	–	Sell	-1,986	Closed	-$226K	–	376
2024 Q3	$226K	Sell	1,986 -950	-32%	-$113K	0.01%	356
2024 Q2	$364K	Sell	2,936 -34	-1%	-$4.38K	0.01%	337
2024 Q1	$392K	Sell	2,970 -392	-12%	-$48.3K	0.01%	336
2023 Q4	$367K	Hold	3,362	–	–	0.01%	350
2023 Q3	$346K	Hold	3,362	–	–	0.01%	344
2023 Q2	$388K	Buy	3,362 +51	+2%	+$5.79K	0.01%	339
2023 Q1	$352K	Hold	3,311	–	–	0.01%	360
2022 Q4	$367K	Buy	+3,311	New	+$338K	0.01%	371

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Palisade Capital Management's MRK Position: Q1 2026 in Review

Palisade Capital Management held its Merck (MRK) position steady in Q1 2026 at 2,014 shares worth $242K. The position accounts for 0.01% of the portfolio, ranked #296.

Palisade Capital Management first reported a position in MRK in Q4 2022 and has held it in 11 quarters since. The position peaked at $392K in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Palisade Capital Management held 2,014 shares of Merck worth $242K as of Q1 2026.
Palisade Capital Management left its Merck share count unchanged in Q1 2026.
Merck made up 0.01% of Palisade Capital Management's portfolio in Q1 2026, its #296 holding.
Palisade Capital Management first reported a position in Merck in Q4 2022 and has held it in 11 quarters since.
Palisade Capital Management's Merck position peaked at $392K in Q1 2024.
3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Palisade Capital Management's 13F filing for Q1 2026, filed 15 May 2026.